Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text PDF (Full Text) Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JCB Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Czekay, R.-P. Articles by Loskutoff, D. J. Search for Related Content PubMed PubMed Citation Articles by Czekay, R.-P. Articles by Loskutoff, D. J. Related Collections Related Article Social Bookmarking                      What's this?

The Scripps Research Institute, Department of Cell Biology, Division of Vascular Biology, 10550 N. Torrey Pines Road, VB-3, La Jolla, CA 92037

Address correspondence to David J. Loskutoff, The Scripps Research Institute, Dept. of Cell Biology, Div. of Vascular Biology, 10550 N. Torrey Pines Rd., VB-3, La Jolla, CA 92037. Tel.: (858) 784-7125. Fax: (858) 784-7353. E-mail: loskutof{at}scripps.edu

The binding of urokinase plaminogen activator (uPA) to its cell surface receptor (uPAR; CD87) promotes cell adhesion by increasing the affinity of the receptor for both vitronectin (VN) and integrins. We provide evidence that plasminogen activator inhibitor (PAI)-1 can detach cells by disrupting uPAR–VN and integrin–VN interactions and that it does so by binding to the uPA present in uPA–uPAR–integrin complexes on the cell surface. The detached cells cannot reattach to VN unless their surface integrins are first activated by treatment with MnCl₂. Immunoprecipitation and subcellular fractionation experiments reveal that PAI-1 treatment triggers deactivation and disengagement of uPA–uPAR–integrin complexes and their endocytic clearance by the low density lipoprotein receptor–related protein. Transfection experiments demonstrate that efficient cell detachment by PAI-1 requires an excess of matrix-engaged uPA–uPAR–integrin complexes over free engaged integrins and that changes in this ratio alter the efficacy of PAI-1. Together, these results suggest a VN-independent, uPA–uPAR-dependent mechanism by which PAI-1 induces cell detachment. This pathway may represent a general mechanism, since PAI-1 also can detach cells from fibronectin and type-1 collagen. This novel "deadhesive" activity of PAI-1 toward a variety of cells growing on different extracellular matrices may begin to explain why high PAI-1 levels often are associated with a poor prognosis in human metastatic disease.

Key Words: uPAR (CD87); vitronectin; fibronectin; integrin deactivation; endocytosis

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Article

A protease inhibitor unsticks cells

Nicole LeBrasseur
J. Cell Biol. 2003 160: 625. [Full Text] [PDF]

This article has been cited by other articles:

• Shah, C., Yang, G., Lee, I., Bielawski, J., Hannun, Y. A., Samad, F. (2008). Protection from High Fat Diet-induced Increase in Ceramide in Mice Lacking Plasminogen Activator Inhibitor 1. J. Biol. Chem. 283: 13538-13548 [Abstract] [Full Text]  
• Vial, D., McKeown-Longo, P. J. (2008). PAI1 stimulates assembly of the fibronectin matrix in osteosarcoma cells through crosstalk between the {alpha}v{beta}5 and {alpha}5{beta}1 integrins. J. Cell Sci. 121: 1661-1670 [Abstract] [Full Text]  
• Vaupel, P. (2008). Hypoxia and Aggressive Tumor Phenotype: Implications for Therapy and Prognosis. The Oncologist 13: 21-26 [Abstract] [Full Text]  
• Schar, C. R., Blouse, G. E., Minor, K. H., Peterson, C. B. (2008). A Deletion Mutant of Vitronectin Lacking the Somatomedin B Domain Exhibits Residual Plasminogen Activator Inhibitor-1-binding Activity. J. Biol. Chem. 283: 10297-10309 [Abstract] [Full Text]  
• Thorn, S. R, Purup, S., Vestergaard, M., Sejrsen, K., Meyer, M. J, Van Amburgh, M. E, Boisclair, Y. R (2008). Regulation of mammary parenchymal growth by the fat pad in prepubertal dairy heifers: role of inflammation-related proteins. J Endocrinol 196: 539-546 [Abstract] [Full Text]  
• Paugh, B. S., Paugh, S. W., Bryan, L., Kapitonov, D., Wilczynska, K. M., Gopalan, S. M., Rokita, H., Milstien, S., Spiegel, S., Kordula, T. (2008). EGF regulates plasminogen activator inhibitor-1 (PAI-1) by a pathway involving c-Src, PKC{delta}, and sphingosine kinase 1 in glioblastoma cells. FASEB J. 22: 455-465 [Abstract] [Full Text]  
• Tsai, M.-S., Hwang, S.-M., Chen, K.-D., Lee, Y.-S., Hsu, L.-W., Chang, Y.-J., Wang, C.-N., Peng, H.-H., Chang, Y.-L., Chao, A.-S., Chang, S.-D., Lee, K.-D., Wang, T.-H., Wang, H.-S., Soong, Y.-K. (2007). Functional Network Analysis of the Transcriptomes of Mesenchymal Stem Cells Derived from Amniotic Fluid, Amniotic Membrane, Cord Blood, and Bone Marrow. Stem Cells 25: 2511-2523 [Abstract] [Full Text]  
• Jost, M., Maillard, C., Lecomte, J., Lambert, V., Tjwa, M., Blaise, P., Alvarez Gonzalez, M.-L., Bajou, K., Blacher, S., Motte, P., Humblet, C., Defresne, M. P., Thiry, M., Frankenne, F., Gothot, A., Carmeliet, P., Rakic, J.-M., Foidart, J.-M., Noel, A. (2007). Tumoral and Choroidal Vascularization: Differential Cellular Mechanisms Involving Plasminogen Activator Inhibitor Type I. Am. J. Pathol. 171: 1369-1380 [Abstract] [Full Text]  
• Zemskov, E. A., Mikhailenko, I., Strickland, D. K., Belkin, A. M. (2007). Cell-surface transglutaminase undergoes internalization and lysosomal degradation: an essential role for LRP1. J. Cell Sci. 120: 3188-3199 [Abstract] [Full Text]  
• Arciniegas, E., Frid, M. G., Douglas, I. S., Stenmark, K. R. (2007). Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension. Am. J. Physiol. Lung Cell. Mol. Physiol. 293: L1-L8 [Abstract] [Full Text]  
• Bernstein, A. M., Twining, S. S., Warejcka, D. J., Tall, E., Masur, S. K. (2007). Urokinase Receptor Cleavage: A Crucial Step in Fibroblast-to-Myofibroblast Differentiation. Mol. Biol. Cell 18: 2716-2727 [Abstract] [Full Text]  
• Fay, W. P., Garg, N., Sunkar, M. (2007). Vascular Functions of the Plasminogen Activation System. Arterioscler. Thromb. Vasc. Bio. 27: 1231-1237 [Abstract] [Full Text]  
• Stefansson, S., Su, E. J., Ishigami, S., Cale, J. M., Gao, Y., Gorlatova, N., Lawrence, D. A. (2007). The Contributions of Integrin Affinity and Integrin-Cytoskeletal Engagement in Endothelial and Smooth Muscle Cell Adhesion to Vitronectin. J. Biol. Chem. 282: 15679-15689 [Abstract] [Full Text]  
• Otsuka, G., Stempien-Otero, A., Frutkin, A. D., Dichek, D. A. (2007). Mechanisms of TGF-{beta}1-Induced Intimal Growth: Plasminogen-Independent Activities of Plasminogen Activator Inhibitor-1 and Heterogeneous Origin of Intimal Cells. Circ. Res. 100: 1300-1307 [Abstract] [Full Text]  
• Gorlatova, N. V., Cale, J. M., Elokdah, H., Li, D., Fan, K., Warnock, M., Crandall, D. L., Lawrence, D. A. (2007). Mechanism of Inactivation of Plasminogen Activator Inhibitor-1 by a Small Molecule Inhibitor. J. Biol. Chem. 282: 9288-9296 [Abstract] [Full Text]  
• Wei, Y., Tang, C.-H., Kim, Y., Robillard, L., Zhang, F., Kugler, M. C., Chapman, H. A. (2007). Urokinase Receptors Are Required for {alpha}5beta1 Integrin-mediated Signaling in Tumor Cells. J. Biol. Chem. 282: 3929-3939 [Abstract] [Full Text]  
• Maquerlot, F., Galiacy, S., Malo, M., Guignabert, C., Lawrence, D. A., d'Ortho, M.-P., Barlovatz-Meimon, G. (2006). Dual Role for Plasminogen Activator Inhibitor Type 1 as Soluble and as Matricellular Regulator of Epithelial Alveolar Cell Wound Healing. Am. J. Pathol. 169: 1624-1632 [Abstract] [Full Text]  
• Oh, S.-H., Lee, O.-H., Schroeder, C. P., Oh, Y. W., Ke, S., Cha, H.-J., Park, R.-W., Onn, A., Herbst, R. S., Li, C., Lee, H.-Y. (2006). Antimetastatic activity of insulin-like growth factor binding protein-3 in lung cancer is mediated by insulin-like growth factor-independent urokinase-type plasminogen activator inhibition.. Molecular Cancer Therapeutics 5: 2685-2695 [Abstract] [Full Text]  
• Eddy, A. A., Fogo, A. B. (2006). Plasminogen Activator Inhibitor-1 in Chronic Kidney Disease: Evidence and Mechanisms of Action. J. Am. Soc. Nephrol. 17: 2999-3012 [Full Text]  
• Wang, X.-Q., Bdeir, K., Yarovoi, S., Cines, D. B., Fang, W., Abraham, E. (2006). Involvement of the Urokinase Kringle Domain in Lipopolysaccharide-Induced Acute Lung Injury. J. Immunol. 177: 5550-5557 [Abstract] [Full Text]  
• Akkawi, S., Nassar, T., Tarshis, M., Cines, D. B., Higazi, A. A.-R. (2006). LRP and {alpha}vbeta3 mediate tPA activation of smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 291: H1351-H1359 [Abstract] [Full Text]  
• Yin, S., Lockett, J., Meng, Y., Biliran, H. Jr., Blouse, G. E., Li, X., Reddy, N., Zhao, Z., Lin, X., Anagli, J., Cher, M. L., Sheng, S. (2006). Maspin Retards Cell Detachment via a Novel Interaction with the Urokinase-Type Plasminogen Activator/Urokinase-Type Plasminogen Activator Receptor System.. Cancer Res. 66: 4173-4181 [Abstract] [Full Text]  
• Otsuka, G., Agah, R., Frutkin, A. D., Wight, T. N., Dichek, D. A. (2006). Transforming Growth Factor Beta 1 Induces Neointima Formation Through Plasminogen Activator Inhibitor-1-Dependent Pathways. Arterioscler. Thromb. Vasc. Bio. 26: 737-743 [Abstract] [Full Text]  
• Ramy, R E., Verot, A, Mazaud, S, Odet, F, Magre, S, Le Magueresse-Battistoni, B (2005). Fibroblast growth factor (FGF) 2 and FGF9 mediate mesenchymal-epithelial interactions of peritubular and Sertoli cells in the rat testis. J Endocrinol 187: 135-147 [Abstract] [Full Text]  
• Arndt, P. G., Young, S. K., Worthen, G. S. (2005). Regulation of Lipopolysaccharide-Induced Lung Inflammation by Plasminogen Activator Inhibitor-1 through a JNK-Mediated Pathway. J. Immunol. 175: 4049-4059 [Abstract] [Full Text]  
• Degryse, B., Resnati, M., Czekay, R.-P., Loskutoff, D. J., Blasi, F. (2005). Domain 2 of the Urokinase Receptor Contains an Integrin-interacting Epitope with Intrinsic Signaling Activity: GENERATION OF A NEW INTEGRIN INHIBITOR. J. Biol. Chem. 280: 24792-24803 [Abstract] [Full Text]  
• Dan, J., Belyea, D., Gertner, G., Leshem, I., Lusky, M., Miskin, R. (2005). Plasminogen Activator Inhibitor-1 in the Aqueous Humor of Patients With and Without Glaucoma. Arch Ophthalmol 123: 220-224 [Abstract] [Full Text]  
• Wei, Y., Czekay, R.-P., Robillard, L., Kugler, M. C., Zhang, F., Kim, K. K., Xiong, J.-p., Humphries, M. J., Chapman, H. A. (2005). Regulation of {alpha}5{beta}1 integrin conformation and function by urokinase receptor binding. J. Cell Biol. 168: 501-511 [Abstract] [Full Text]  
• Spijkers, P. P. E. M., da Costa Martins, P., Westein, E., Gahmberg, C. G., Zwaginga, J. J., Lenting, P. J. (2005). LDL-receptor-related protein regulates {beta}2-integrin-mediated leukocyte adhesion. Blood 105: 170-177 [Abstract] [Full Text]  
• Czekay, R.-P., Loskutoff, D. J. (2004). Unexpected Role of Plasminogen Activator Inhibitor 1 in Cell Adhesion and Detachment. Exp. Biol. Med. 229: 1090-1096 [Abstract] [Full Text]  
• Lazar, M. H., Christensen, P. J., Du, M., Yu, B., Subbotina, N. M., Hanson, K. E., Hansen, J. M., White, E. S., Simon, R. H., Sisson, T. H. (2004). Plasminogen Activator Inhibitor-1 Impairs Alveolar Epithelial Repair by Binding to Vitronectin. Am. J. Respir. Cell Mol. Bio. 31: 672-678 [Abstract] [Full Text]  
• Das, A., Boyd, N., Jones, T. R., Talarico, N., McGuire, P. G. (2004). Inhibition of Choroidal Neovascularization by a Peptide Inhibitor of the Urokinase Plasminogen Activator and Receptor System in a Mouse Model. Arch Ophthalmol 122: 1844-1849 [Abstract] [Full Text]  
• Vaupel, P. (2004). The Role of Hypoxia-Induced Factors in Tumor Progression. The Oncologist 9: 10-17 [Abstract] [Full Text]  
• Noel, A, Maillard, C, Rocks, N, Jost, M, Chabottaux, V, Sounni, N E, Maquoi, E, Cataldo, D, Foidart, J M (2004). Membrane associated proteases and their inhibitors in tumour angiogenesis. J. Clin. Pathol. 57: 577-584 [Abstract] [Full Text]  
• Degryse, B., Neels, J. G., Czekay, R.-P., Aertgeerts, K., Kamikubo, Y.-i., Loskutoff, D. J. (2004). The Low Density Lipoprotein Receptor-related Protein Is a Motogenic Receptor for Plasminogen Activator Inhibitor-1. J. Biol. Chem. 279: 22595-22604 [Abstract] [Full Text]  
• Wang, H., Yang, L., Jamaluddin, Md. S., Boyd, D. D. (2004). The Kruppel-like KLF4 Transcription Factor, a Novel Regulator of Urokinase Receptor Expression, Drives Synthesis of This Binding Site in Colonic Crypt Luminal Surface Epithelial Cells. J. Biol. Chem. 279: 22674-22683 [Abstract] [Full Text]  
• Ray, N., Enquist, L. W. (2004). Transcriptional Response of a Common Permissive Cell Type to Infection by Two Diverse Alphaherpesviruses. J. Virol. 78: 3489-3501 [Abstract] [Full Text]  
• Salicioni, A. M., Gaultier, A., Brownlee, C., Cheezum, M. K., Gonias, S. L. (2004). Low Density Lipoprotein Receptor-related Protein-1 Promotes {beta}1 Integrin Maturation and Transport to the Cell Surface. J. Biol. Chem. 279: 10005-10012 [Abstract] [Full Text]  
• Ma, L.-J., Mao, S.-L., Taylor, K. L., Kanjanabuch, T., Guan, Y., Zhang, Y., Brown, N. J., Swift, L. L., McGuinness, O. P., Wasserman, D. H., Vaughan, D. E., Fogo, A. B. (2004). Prevention of Obesity and Insulin Resistance in Mice Lacking Plasminogen Activator Inhibitor 1. Diabetes 53: 336-346 [Abstract] [Full Text]  
• Michel, J.-B. (2003). Anoikis in the Cardiovascular System: Known and Unknown Extracellular Mediators. Arterioscler. Thromb. Vasc. Bio. 23: 2146-2154 [Abstract] [Full Text]  
• Palumbo, J. S., Talmage, K. E., Liu, H., La Jeunesse, C. M., Witte, D. P., Degen, J. L. (2003). Plasminogen supports tumor growth through a fibrinogen-dependent mechanism linked to vascular patency. Blood 102: 2819-2827 [Abstract] [Full Text]  
• Tarui, T., Andronicos, N., Czekay, R.-P., Mazar, A. P., Bdeir, K., Parry, G. C., Kuo, A., Loskutoff, D. J., Cines, D. B., Takada, Y. (2003). Critical Role of Integrin {alpha}5{beta}1 in Urokinase (uPA)/Urokinase Receptor (uPAR, CD87) Signaling. J. Biol. Chem. 278: 29863-29872 [Abstract] [Full Text]  
• Stefansson, S., Lawrence, D. A. (2003). Old Dogs and New Tricks, Proteases, Inhibitors, and Cell Migration. Sci Signal 2003: pe24-pe24 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents